Andrew R Draganski

Zylo Therapeutics, Inc.

NIH Rank #49897
  • Early Career

NIH Funding · FY2024

Total Funding
$145.9K
Fiscal year 2024
Grants Awarded
1
Active NIH grants
National Rank
#49,897
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $145.9K across 1 grant · National rank #49897.

Top grants by award amount

Andrew R Draganski's NIH grant portfolio, ranked by award amount.

  • 5R41AR082749-02R41
    Development of an endocannabinoid microparticle formulation for the topical treatment of cutaneous manifestations of lupus erythematosus.
    $145.9K
    award amount

Affiliation

Institutions that have administered grants for Andrew R Draganski.

Affiliated with Zylo Therapeutics, Inc. (SC).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Zylo Therapeutics, Inc.

Related investigators

Other NIH-funded PIs frequently associated with Andrew R Draganski.